Na+/H+ exchanger 1 inhibition contributes to K562 leukaemic cell differentiation. 2012

Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing Road 288, Tianjin 300020, Peoples Republic of China.

The effect of hypoxia on the differentiation of chronic myeloid leukaemic K562 cells were studied, as was the role of the NHE1 (Na+/H+ exchanger 1). Hypoxia induced differentiation of K562 cells as seen by modifications in their morphological features, up-regulation of C/EBPα (CCAAT/enhancer-binding protein α), and marked IL-8 (interleukin-8) release. Inhibition of NHE1 under hypoxia additionally enhanced the level of C/EBPα and further promoted leukaemic cells differentiation. Pharmacological inhibition of p38 MAPK (mitogen-activated protein kinase) also significantly suppressed C/EBPα expression under hypoxia conditions after NHE1 inhibition. These results indicate the enhancement of hypoxia-induced K562 differentiation by NHE1 inhibition, which may be due to up-regulation of C/EBPα via p38 MAPK signalling pathway, which suggests a possible therapeutic target of NHE1 under hypoxia microenvironment in the treatment of leukaemic diseases.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003035 Cobalt A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis. Cobalt-59,Cobalt 59
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000074082 Sodium-Hydrogen Exchanger 1 A sodium-hydrogen antiporter expressed by many cell types, especially on the basolateral surfaces of EPITHELIAL CELLS. It functions through an inward sodium ion chemical gradient to eliminate acids (protons) generated by metabolism and regulate intracellular pH. It is highly sensitive to AMILORIDE. Na(+)-H(+) Exchanger 1,SLC9A1 Protein,Solute Carrier Family 9 Member 1,Sodium Hydrogen Exchanger 1
D013450 Sulfones Sulfone
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015687 Cell Hypoxia A condition of decreased oxygen content at the cellular level. Anoxia, Cellular,Cell Anoxia,Hypoxia, Cellular,Anoxia, Cell,Anoxias, Cell,Anoxias, Cellular,Cell Anoxias,Cell Hypoxias,Cellular Anoxia,Cellular Anoxias,Cellular Hypoxia,Cellular Hypoxias,Hypoxia, Cell,Hypoxias, Cell,Hypoxias, Cellular

Related Publications

Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
January 2009, American journal of physiology. Heart and circulatory physiology,
Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
September 2014, Leukemia research,
Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
September 2013, Journal of cellular and molecular medicine,
Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
September 2008, American journal of physiology. Renal physiology,
Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
January 2005, The international journal of biochemistry & cell biology,
Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
September 2010, Journal of neurochemistry,
Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
April 2002, Circulation research,
Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
March 1996, Nihon rinsho. Japanese journal of clinical medicine,
Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
March 1999, International journal of molecular medicine,
Weina Jin, and Qinghua Li, and Jian Wang, and Guoqiang Chang, and Yani Lin, and Huawen Li, and Lihong Wang, and Wei Gao, and Tianxiang Pang
January 2006, Current vascular pharmacology,
Copied contents to your clipboard!